Stem Cell Spheroids Reverse Muscle Wasting in Sarcopenia Rat Model

Sarcopenia — the progressive loss of skeletal muscle mass, strength, and function — is a growing concern in aging populations and in patients receiving prolonged glucocorticoid therapy. Existing pharmacological options remain limited, making cell-based regenerative strategies an attractive frontier. This study from Ewha Womans University explored whether 3D spheroids derived from tonsil mesenchymal stem cells (TMSCs) differentiated into skeletal muscle cells could reverse sarcopenic changes in a preclinical rat model.

TMSCs were first differentiated into skeletal muscle cells (SKMCs) in vitro, leveraging the previously established myogenic differentiation capacity of this readily accessible, ethically uncontroversial cell source. The differentiated cells were then assembled into compact 3D spheroids using microwell platforms — a technique that promotes cell–cell contact, improves viability, and amplifies secretion of regenerative factors compared to monolayer culture. Sarcopenia was induced in rats via systemic dexamethasone (DEX) administration, which reliably produces muscle atrophy mimicking key clinical features of the disease including reduced muscle mass, impaired strength, and functional decline.

Following intramuscular transplantation of TMSC-SKMC-spheroids into the gastrocnemius muscle of DEX-treated rats, multiple outcome measures demonstrated therapeutic benefit. Grip strength tests and running fatigue assessments revealed significant improvements in hind limb motor function. Gastrocnemius muscle thickness and weight — direct indices of muscle mass — were substantially recovered in the transplantation group relative to untreated atrophy controls. Histopathological analyses confirmed muscle fiber regeneration at the tissue level, and notably, neuromuscular junction (NMJ) integrity was restored in transplanted animals, a particularly important finding given that NMJ deterioration is a hallmark of sarcopenia and contributes to functional impairment.

The restoration of NMJs is mechanistically significant: it implies that transplanted spheroids not only contributed directly to muscle fiber regeneration but also supported the re-establishment of neural connectivity essential for coordinated muscle contraction. This dual effect — structural and functional recovery — strengthens the therapeutic case for this approach. The 3D spheroid format likely confers advantages over dissociated cell injections by protecting cells from anoikis, sustaining localized paracrine signaling (growth factors, exosomes), and improving engraftment efficiency.

While results are promising, the study is preclinical and limited to a single animal model of pharmacologically induced atrophy. Translation to human sarcopenia, which involves complex multifactorial pathology including neurodegeneration, hormonal changes, and chronic inflammation, will require further validation. Nonetheless, these findings position TMSC-SKMC-spheroids as a compelling, scalable cell therapy candidate worthy of accelerated investigation.